Header Logo

Connection

LANLAN SHEN to Clinical Trials, Phase III as Topic

Back to Details
This is a "connection" page, showing publications LANLAN SHEN has written about Clinical Trials, Phase III as Topic.
LANLAN SHEN
Connection Strength
0.084
Clinical Trials, Phase III as Topic
  1. DNA methylation predicts survival and response to therapy in patients with myelodysplastic syndromes. J Clin Oncol. 2010 Feb 01; 28(4):605-13.
    View in: PubMed
    Score: 0.084
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.